Magle Chemoswed Holding AB (publ)

OM:MAGLE Stock Report

Market Cap: SEK 442.8m

Magle Chemoswed Holding Past Earnings Performance

Past criteria checks 2/6

Magle Chemoswed Holding has been growing earnings at an average annual rate of 26.7%, while the Life Sciences industry saw earnings growing at 26.7% annually. Revenues have been growing at an average rate of 11.3% per year. Magle Chemoswed Holding's return on equity is 4.8%, and it has net margins of 4.3%.

Key information

26.7%

Earnings growth rate

19.8%

EPS growth rate

Life Sciences Industry Growth31.8%
Revenue growth rate11.3%
Return on equity4.8%
Net Margin4.3%
Next Earnings Update24 Oct 2024

Recent past performance updates

Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality

Apr 26
Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality

Recent updates

Market Participants Recognise Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Earnings Pushing Shares 37% Higher

Jun 26
Market Participants Recognise Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Earnings Pushing Shares 37% Higher

Magle Chemoswed Holding (STO:MAGLE) Has A Pretty Healthy Balance Sheet

Jun 19
Magle Chemoswed Holding (STO:MAGLE) Has A Pretty Healthy Balance Sheet

Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality

Apr 26
Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality

Earnings Tell The Story For Magle Chemoswed Holding AB (publ) (STO:MAGLE) As Its Stock Soars 28%

Mar 29
Earnings Tell The Story For Magle Chemoswed Holding AB (publ) (STO:MAGLE) As Its Stock Soars 28%

Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Price In Tune With Earnings

Oct 05
Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Price In Tune With Earnings

Should You Be Impressed By Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) ROE?

Jan 22
Should You Be Impressed By Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) ROE?

Revenue & Expenses Breakdown

How Magle Chemoswed Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:MAGLE Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2417981380
31 Mar 24171121320
31 Dec 23171121310
30 Sep 23170101310
30 Jun 2315891210
31 Mar 2315581200
31 Dec 2214891130
30 Sep 22138101060
30 Jun 22136101080
31 Mar 2213371060
31 Dec 2113241060
30 Sep 2113731050
30 Jun 211331990
31 Mar 211342990
31 Dec 2014221000
30 Sep 20151141030
30 Jun 2014081040
31 Mar 2013711000
31 Dec 191321960
31 Dec 18110-3990

Quality Earnings: MAGLE has high quality earnings.

Growing Profit Margin: MAGLE's current net profit margins (4.3%) are lower than last year (5.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MAGLE has become profitable over the past 5 years, growing earnings by 26.7% per year.

Accelerating Growth: MAGLE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: MAGLE had negative earnings growth (-13%) over the past year, making it difficult to compare to the Life Sciences industry average (-13%).


Return on Equity

High ROE: MAGLE's Return on Equity (4.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.